false 0000855683 0000855683 2024-07-16 2024-07-16
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): July 16, 2024
 
Milestone Scientific Inc.
(Exact name of registrant as specified in its charter)
         
Delaware
(State or other jurisdiction
of incorporation)
  
001-14053
(Commission
File Number)
  
13-3545623
(IRS Employer
Identification No.)
 
     
425 Eagle Rock Avenue, Suite 403
Roseland, NJ
(Address of principal executive offices)
  
07068
(Zip Code)
 
Registrant’s telephone number, including area code (973) 535-2717
 
N/A
(Former name or former address, if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name on exchange on which registered
Common Stock
MLSS
NYSE American
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
Item 5.07         Submission of Matters to a Vote of Security Holders
 
The 2024 Annual Meeting of Stockholders (the “Annual Meeting”) of Milestone Scientific Inc. (the “Company”) was held on July 16, 2024. At the Annual Meeting, the Company’s stockholders:
 
 
●
Elected seven incumbent directors to serve until the next annual meeting of the Company’s stockholders or until their respective successors have been duly elected and qualified; and
 
●
Ratified the appointment of Marcum LLP as the Company’s independent auditors for the fiscal year ending December 31, 2024.
 
The total number of shares outstanding at the record date for the Annual Meeting were 77,227,714 shares of common stock. The total number of shares of common stock voted at the Annual Meeting were 51,388,906 shares of common stock, representing 66.54% of the issued and outstanding shares of common stock.
 
The number of votes cast for, against or withheld and the number of abstentions and broker non-votes with respect to each Proposal is set forth below.
 
Proposal 1
Election of Directors
  
Shares For
    
Shares
Withheld
    
Broker Non-
Votes
  
Neal Goldman
  
30,072,211
    
878,517
    
20,438,178
  
Leonard Osser
  
30,050,431
    
900,297
    
20,438,178
  
Benedetta I. Casamento
  
30,041,036
    
909,692
    
20,438,178
  
Michael McGeehan
  
30,010,329
    
940,399
    
20,438,178
  
Gian Domenico Trombetta
  
30,287,522
    
663,206
    
20,438,178
  
Arjan Haverhals
  
30,410,523
    
540,205
    
20,438,178
  
Dr. Didier Demesmin
  
30,572,148
    
378,580
    
20,438,178
  
 
Proposal 2
Ratification of Auditors
  
Shares
For
    
Shares
Against
    
Shares
Abstaining
    
Broker
Non-
Votes
  
Ratification of the appointment of Marcum LLP as the Company’s independent auditors for the fiscal year ending December 31, 2024
  
51,088,398
    
280,481
    
20,027
    
--
  
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 
         
 
MILESTONE SCIENTIFIC INC.
 
  
Dated: July 18, 2024 
By:  
/s/ Arjan Haverhals
  
   
Arjan Haverhals,
  
   
Chief Executive Officer
  
 
 
 
v3.24.2
Document And Entity Information
Jul. 16, 2024
Document Information [Line Items]  
Entity, Registrant Name Milestone Scientific Inc.
Document, Type 8-K
Document, Period End Date Jul. 16, 2024
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-14053
Entity, Tax Identification Number 13-3545623
Entity, Address, Address Line One 425 Eagle Rock Avenue, Suite 403
Entity, Address, City or Town Roseland
Entity, Address, State or Province NJ
Entity, Address, Postal Zip Code 07068
City Area Code 973
Local Phone Number 535-2717
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol MLSS
Security Exchange Name NYSE
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0000855683
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Milestone Scientific Charts.
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Milestone Scientific Charts.